The average waiting time for a neurology consultation in the National Health Service is seven months. This value represents a significant delay in patients' access to specialized neurological healthcare.
The situation has serious consequences for patients, particularly regarding the timely diagnosis of neurodegenerative diseases. The delay in consultation can compromise the early identification of pathologies such as Alzheimer's disease.
The impact of this prolonged wait affects not only diagnosis, but also the initiation of treatments that could be more effective if started in earlier stages of neurological diseases.
